315 related articles for article (PubMed ID: 35197069)
21. PrLZ increases prostate cancer docetaxel resistance by inhibiting LKB1/AMPK-mediated autophagy.
Zeng J; Liu W; Fan YZ; He DL; Li L
Theranostics; 2018; 8(1):109-123. PubMed ID: 29290796
[No Abstract] [Full Text] [Related]
22. Caffeic acid phenethyl ester suppressed growth and metastasis of nasopharyngeal carcinoma cells by inactivating the NF-κB pathway.
Liang Y; Feng G; Wu L; Zhong S; Gao X; Tong Y; Cui W; Qin Y; Xu W; Xiao X; Zhang Z; Huang G; Zhou X
Drug Des Devel Ther; 2019; 13():1335-1345. PubMed ID: 31118570
[No Abstract] [Full Text] [Related]
23. Caffeic acid phenethyl ester upregulates N-myc downstream regulated gene 1 via ERK pathway to inhibit human oral cancer cell growth in vitro and in vivo.
Chung LC; Chiang KC; Feng TH; Chang KS; Chuang ST; Chen YJ; Tsui KH; Lee JC; Juang HH
Mol Nutr Food Res; 2017 Sep; 61(9):. PubMed ID: 28181403
[TBL] [Abstract][Full Text] [Related]
24. Inhibiting the NF-κB pathway enhances the antitumor effect of cabazitaxel by downregulating Bcl-2 in pancreatic cancer.
Li Z; Xuan Z; Chen J; Song W; Zhang S; Jin C; Zhou M; Zheng S; Song P
Int J Oncol; 2020 Jul; 57(1):161-170. PubMed ID: 32377719
[TBL] [Abstract][Full Text] [Related]
25. Quercetin reverses docetaxel resistance in prostate cancer via androgen receptor and PI3K/Akt signaling pathways.
Lu X; Yang F; Chen D; Zhao Q; Chen D; Ping H; Xing N
Int J Biol Sci; 2020; 16(7):1121-1134. PubMed ID: 32174789
[TBL] [Abstract][Full Text] [Related]
26. Anti-cancer efficacy of SREBP inhibitor, alone or in combination with docetaxel, in prostate cancer harboring p53 mutations.
Li X; Wu JB; Chung LW; Huang WC
Oncotarget; 2015 Dec; 6(38):41018-32. PubMed ID: 26512780
[TBL] [Abstract][Full Text] [Related]
27. Caffeic acid phenethyl ester suppresses proliferation and survival of TW2.6 human oral cancer cells via inhibition of Akt signaling.
Kuo YY; Lin HP; Huo C; Su LC; Yang J; Hsiao PH; Chiang HC; Chung CJ; Wang HD; Chang JY; Chen YW; Chuu CP
Int J Mol Sci; 2013 Apr; 14(5):8801-17. PubMed ID: 23615471
[TBL] [Abstract][Full Text] [Related]
28. Caffeic acid phenethyl ester causes p21 induction, Akt signaling reduction, and growth inhibition in PC-3 human prostate cancer cells.
Lin HP; Jiang SS; Chuu CP
PLoS One; 2012; 7(2):e31286. PubMed ID: 22347457
[TBL] [Abstract][Full Text] [Related]
29. MiR-129-5p promotes docetaxel resistance in prostate cancer by down-regulating CAMK2N1 expression.
Wu C; Miao C; Tang Q; Zhou X; Xi P; Chang P; Hua L; Ni H
J Cell Mol Med; 2020 Feb; 24(3):2098-2108. PubMed ID: 31876385
[TBL] [Abstract][Full Text] [Related]
30. Apoptosis induced by caffeic acid phenethyl ester in human oral cancer cell lines: Involvement of Puma and Bax activation.
Yu HJ; Shin JA; Yang IH; Won DH; Ahn CH; Kwon HJ; Lee JS; Cho NP; Kim EC; Yoon HJ; Lee JI; Hong SD; Cho SD
Arch Oral Biol; 2017 Dec; 84():94-99. PubMed ID: 28965045
[TBL] [Abstract][Full Text] [Related]
31. EAU guidelines on prostate cancer. Part II: Treatment of advanced, relapsing, and castration-resistant prostate cancer.
Heidenreich A; Bastian PJ; Bellmunt J; Bolla M; Joniau S; van der Kwast T; Mason M; Matveev V; Wiegel T; Zattoni F; Mottet N;
Eur Urol; 2014 Feb; 65(2):467-79. PubMed ID: 24321502
[TBL] [Abstract][Full Text] [Related]
32. Androgen receptor (AR) degradation enhancer ASC-J9
Cheng MA; Chou FJ; Wang K; Yang R; Ding J; Zhang Q; Li G; Yeh S; Xu D; Chang C
Cancer Lett; 2018 Mar; 417():182-191. PubMed ID: 29203251
[TBL] [Abstract][Full Text] [Related]
33. Novel CIL-102 derivatives as potential therapeutic agents for docetaxel-resistant prostate cancer.
Miller DR; Tzeng CC; Farmer T; Keller ET; Caplan S; Chen YS; Chen YL; Lin MF
Cancer Lett; 2018 Nov; 436():96-108. PubMed ID: 30077739
[TBL] [Abstract][Full Text] [Related]
34. Caffeic acid phenethyl ester as an adjuvant therapy for advanced prostate cancer.
Liu CC; Hsu JM; Kuo LK; Chuu CP
Med Hypotheses; 2013 May; 80(5):617-9. PubMed ID: 23462369
[TBL] [Abstract][Full Text] [Related]
35. Targeting the Vav3 oncogene enhances docetaxel-induced apoptosis through the inhibition of androgen receptor phosphorylation in LNCaP prostate cancer cells under chronic hypoxia.
Nomura T; Yamasaki M; Hirai K; Inoue T; Sato R; Matsuura K; Moriyama M; Sato F; Mimata H
Mol Cancer; 2013 Apr; 12():27. PubMed ID: 23566222
[TBL] [Abstract][Full Text] [Related]
36. Combination therapy with novel androgen receptor antagonists and statin for castration-resistant prostate cancer.
Nakayama H; Sekine Y; Oka D; Miyazawa Y; Arai S; Koike H; Matsui H; Shibata Y; Suzuki K
Prostate; 2022 Feb; 82(3):314-322. PubMed ID: 34843630
[TBL] [Abstract][Full Text] [Related]
37. Caffeic acid phenethyl ester suppresses melanoma tumor growth by inhibiting PI3K/AKT/XIAP pathway.
Pramanik KC; Kudugunti SK; Fofaria NM; Moridani MY; Srivastava SK
Carcinogenesis; 2013 Sep; 34(9):2061-70. PubMed ID: 23640046
[TBL] [Abstract][Full Text] [Related]
38. ROR2 suppresses metastasis of prostate cancer via regulation of miR-199a-5p-PIAS3-AKT2 signaling axis.
Tseng JC; Huang SH; Lin CY; Wang BJ; Huang SF; Shen YY; Chuu CP
Cell Death Dis; 2020 May; 11(5):376. PubMed ID: 32415173
[TBL] [Abstract][Full Text] [Related]
39. The Role of Crosstalk between AR3 and E2F1 in Drug Resistance in Prostate Cancer Cells.
Xu J; Yang X; Deshmukh D; Chen H; Fang S; Qiu Y
Cells; 2020 Apr; 9(5):. PubMed ID: 32354165
[TBL] [Abstract][Full Text] [Related]
40. The Effects and Mechanism of YK-4-279 in Combination with Docetaxel on Prostate Cancer.
Yu L; Wu X; Chen M; Huang H; He Y; Wang H; Li D; Du Z; Zhang K; Goodin S; Zheng X
Int J Med Sci; 2017; 14(4):356-366. PubMed ID: 28553168
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
